Skip to main content
Top
Published in: Pediatric Nephrology 4/2006

01-04-2006 | Original Article

Serum cystatin C levels in children with sickle cell disease

Authors: Ofelia Alvarez, Gaston Zilleruelo, Dale Wright, Brenda Montane, Gabriela Lopez-Mitnik

Published in: Pediatric Nephrology | Issue 4/2006

Login to get access

Abstract

Patients with sickle cell disease (SCD) may develop kidney dysfunction from childhood. The purpose of this study was to examine the value of serum cystatin C as a marker for glomerular filtration rate (GFR) in children with SCD, as compared to serum creatinine and creatinine clearance (CrCl). Twenty children (ages 9–21, ten males) with SCD with and without albuminuria were studied. The mean serum cystatin for the whole group was 0.89 mg/l (0.5–1.7 mg/l). Mean serum cystatin C was significantly different among the children with proteinuria (n=4), microalbuminuria (n=5), and without albuminuria (n=11) (1.25 mg/l, 0.84 mg/l, and 0.78 mg/l, respectively). The mean GFR derived from serum cystatin was significantly different among these subgroups, becoming abnormal in the proteinuric cohort (63 ml/min per 1.73 m2), in contrast to 94 for the microalbuminuric, and 103 for the normal subgroups. Serum creatinine (mean: 0.58 mg/dl, range: 0.3–1.1) did not change significantly with the level of albuminuria. Mean CrCl remained normal to increased within the subgroups, (133 ml/min per 1.73 m2 for those with proteinuria, 144 for those with microalbuminuria, and 163 for the normal subgroup). We conclude that serum cystatin C correlates with the level of albuminuria and may be a reliable method to measure renal function in SCD.
Literature
1.
go back to reference Pham PT, Pham C, Wilkinson AH, Lew SQ (2000) Renal abnormalities in sickle cell disease. Kidney Int 57:1–8CrossRefPubMed Pham PT, Pham C, Wilkinson AH, Lew SQ (2000) Renal abnormalities in sickle cell disease. Kidney Int 57:1–8CrossRefPubMed
2.
go back to reference Osarogiagbon UR, Choong S, Belcher JD, Vercelotti GM, Paller MS, Hebbel RP (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96:314–320PubMed Osarogiagbon UR, Choong S, Belcher JD, Vercelotti GM, Paller MS, Hebbel RP (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96:314–320PubMed
3.
4.
go back to reference Sklar AH, Campbell H, Caruana RJ, Lightfoot BO, Gaier JG, Milner P (1990) A population study of renal function in sickle cell anemia. Int J Artif Organs 13:231–236PubMed Sklar AH, Campbell H, Caruana RJ, Lightfoot BO, Gaier JG, Milner P (1990) A population study of renal function in sickle cell anemia. Int J Artif Organs 13:231–236PubMed
5.
go back to reference Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910–915PubMedCrossRef Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910–915PubMedCrossRef
6.
go back to reference Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors in early death. N Engl J Med 330:1639–1644CrossRefPubMed Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors in early death. N Engl J Med 330:1639–1644CrossRefPubMed
7.
go back to reference Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339:1448–1456CrossRefPubMed Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339:1448–1456CrossRefPubMed
8.
go back to reference Guasch A, Cua M, Mitch WE (1996) Early detection and course of glomerular injury in patients with sickle cell anemia. Kidney Int 49:786–791PubMedCrossRef Guasch A, Cua M, Mitch WE (1996) Early detection and course of glomerular injury in patients with sickle cell anemia. Kidney Int 49:786–791PubMedCrossRef
9.
go back to reference Weber JA, Van Zanten AP (1991) Interferences in current methods for measurements of creatinine. Clin Chem 37:695–700PubMed Weber JA, Van Zanten AP (1991) Interferences in current methods for measurements of creatinine. Clin Chem 37:695–700PubMed
10.
go back to reference Swaminathan R, Major P, Snieder H, Spector T (2000) Serum creatinine and fat-free mass (lean body mass). Clin Chem 46:1695–1696PubMed Swaminathan R, Major P, Snieder H, Spector T (2000) Serum creatinine and fat-free mass (lean body mass). Clin Chem 46:1695–1696PubMed
11.
go back to reference Filler G, Bokenkamp A, Hoffman W, Le Bricon T, Martinez-Bru C, Grubb A (2005) Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38:1–8CrossRefPubMed Filler G, Bokenkamp A, Hoffman W, Le Bricon T, Martinez-Bru C, Grubb A (2005) Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38:1–8CrossRefPubMed
12.
go back to reference Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J (1998) Cystatin C—a new marker of glomerular filtration rate in children independent of height and age. Pediatrics 101:875–881CrossRefPubMed Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J (1998) Cystatin C—a new marker of glomerular filtration rate in children independent of height and age. Pediatrics 101:875–881CrossRefPubMed
13.
go back to reference Newman D, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47:312–318PubMedCrossRef Newman D, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47:312–318PubMedCrossRef
14.
go back to reference Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabeled human cystatin C in the rat. Scand J Clin Lab Invest 56:409–414PubMedCrossRef Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabeled human cystatin C in the rat. Scand J Clin Lab Invest 56:409–414PubMedCrossRef
16.
go back to reference Finney H, Newman DJ, Thakkar H, Fell JME, Price CP (2000) Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 82:71–75CrossRefPubMed Finney H, Newman DJ, Thakkar H, Fell JME, Price CP (2000) Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 82:71–75CrossRefPubMed
17.
go back to reference Finney H, Newman DJ, Gruber W, Merle P, Price CP (1997) Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 43:1016–1022PubMed Finney H, Newman DJ, Gruber W, Merle P, Price CP (1997) Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 43:1016–1022PubMed
18.
go back to reference Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
19.
go back to reference Cockcroft D, Gault M (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef Cockcroft D, Gault M (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
20.
go back to reference Hoek FJ, Kemperman FAW, Krediet RT (2003) A comparison between cystatin C, plasma creatinine, and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18:2024–2031CrossRefPubMed Hoek FJ, Kemperman FAW, Krediet RT (2003) A comparison between cystatin C, plasma creatinine, and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18:2024–2031CrossRefPubMed
21.
go back to reference Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JHH (2005) The Cockcroft-Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JHH (2005) The Cockcroft-Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed
22.
go back to reference Simonsen O, Grubb A, Thysell H (1985) The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45:97–101PubMedCrossRef Simonsen O, Grubb A, Thysell H (1985) The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45:97–101PubMedCrossRef
23.
go back to reference Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A (1994) Serum cystatin C, determined by a rapid, automated particle-enhanced turbidometric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921–1926PubMed Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A (1994) Serum cystatin C, determined by a rapid, automated particle-enhanced turbidometric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921–1926PubMed
24.
go back to reference Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63:1944–1947CrossRefPubMed Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63:1944–1947CrossRefPubMed
25.
go back to reference Bokenkamp A, van Wijk JAE, Lentze MJ, Stoffel-Wagner B (2002) Effect of corticosteroid therapy on serum cystatin C and β2-microglobulin concentrations. Clin Chem 48:1123–1126PubMed Bokenkamp A, van Wijk JAE, Lentze MJ, Stoffel-Wagner B (2002) Effect of corticosteroid therapy on serum cystatin C and β2-microglobulin concentrations. Clin Chem 48:1123–1126PubMed
26.
go back to reference Risch I, Herklotz R, Blumberg A, Hueber AR (2001) Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47:2055–2059PubMed Risch I, Herklotz R, Blumberg A, Hueber AR (2001) Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47:2055–2059PubMed
27.
go back to reference Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G (2004) Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med 256:510–518CrossRefPubMed Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G (2004) Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med 256:510–518CrossRefPubMed
28.
go back to reference Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M (2002) Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61:1453–1461CrossRefPubMed Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M (2002) Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61:1453–1461CrossRefPubMed
29.
go back to reference Tomino Y, Suzuki S, Gohda T, Kobayashi M, Horikoshi S, Imai H, Saito T, Kawamura T, Yorioka N, Harada T, Yasumoto Y, Kida H, Kobayashi Y, Endoh M, Sato H, Saito K (2001) Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 15:25–29CrossRefPubMed Tomino Y, Suzuki S, Gohda T, Kobayashi M, Horikoshi S, Imai H, Saito T, Kawamura T, Yorioka N, Harada T, Yasumoto Y, Kida H, Kobayashi Y, Endoh M, Sato H, Saito K (2001) Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 15:25–29CrossRefPubMed
30.
go back to reference Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, Skibova J, Ryska M, Spicak J, Trunecka P, Novakova J (2002) Glomerular filtration rate assessments in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transplant 8:594–599CrossRef Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, Skibova J, Ryska M, Spicak J, Trunecka P, Novakova J (2002) Glomerular filtration rate assessments in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transplant 8:594–599CrossRef
31.
go back to reference LeBricon T, Thervet E, Benlakehal M, Bouequet B, Legendre C, Erlich D (1999) Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 45:2243–2249PubMed LeBricon T, Thervet E, Benlakehal M, Bouequet B, Legendre C, Erlich D (1999) Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 45:2243–2249PubMed
32.
go back to reference Orlando R, Mussap M, Plebani M, Piccoli P, DeMartin S, Floreani M, Padrini R, Palatini P (2002) Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850–858PubMed Orlando R, Mussap M, Plebani M, Piccoli P, DeMartin S, Floreani M, Padrini R, Palatini P (2002) Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850–858PubMed
33.
go back to reference Dharnirharka VR, Kwon G, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226CrossRefPubMed Dharnirharka VR, Kwon G, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226CrossRefPubMed
34.
go back to reference Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2005) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer DOI: 10.1002/pbc.20645 Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2005) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer DOI: 10.1002/pbc.20645
35.
go back to reference Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749–753CrossRefPubMed Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749–753CrossRefPubMed
36.
go back to reference Zayas CF, Platt J, Eckman JR, Elsas L, Clark WS, Mitch WE, Guasch A (1996) Prevalence and predictors of glomerular involvement in sickle cell anemia (abstract). J Am Soc Nephrol 7:1401 Zayas CF, Platt J, Eckman JR, Elsas L, Clark WS, Mitch WE, Guasch A (1996) Prevalence and predictors of glomerular involvement in sickle cell anemia (abstract). J Am Soc Nephrol 7:1401
37.
go back to reference Aoki RY, Saad ST (1990) Microalbuminuria in sickle cell disease. Braz J Med Biol Res 23:1103–1106PubMed Aoki RY, Saad ST (1990) Microalbuminuria in sickle cell disease. Braz J Med Biol Res 23:1103–1106PubMed
38.
go back to reference Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614–620PubMed Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614–620PubMed
39.
go back to reference Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, Girot R, Bachir D, Galacteros F, Lacour B, Grunfeld JP (1998) Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis 32:208–221PubMed Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, Girot R, Bachir D, Galacteros F, Lacour B, Grunfeld JP (1998) Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis 32:208–221PubMed
40.
go back to reference Herrera J, Avila E, Marin C, Rodriguez-Iturbe B (2002) Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia. Nephrol Dial Transplant 17:602–607CrossRefPubMed Herrera J, Avila E, Marin C, Rodriguez-Iturbe B (2002) Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia. Nephrol Dial Transplant 17:602–607CrossRefPubMed
Metadata
Title
Serum cystatin C levels in children with sickle cell disease
Authors
Ofelia Alvarez
Gaston Zilleruelo
Dale Wright
Brenda Montane
Gabriela Lopez-Mitnik
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 4/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0033-6

Other articles of this Issue 4/2006

Pediatric Nephrology 4/2006 Go to the issue